ASML vs BBIO · P/E 57, $665.37B cap vs rev $221.9M
ASML Holding NV ADR (ASML) versus BridgeBio Pharma Inc (BBIO) — a side-by-side from cached financials, not a winner call.
ASML Holding NV ADR (ASML) is a semiconductor equipment & materials company listed on US.
BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
ASML does not have a complete income-statement cache yet.
Latest reported BBIO revenue for 2024-12-31 was $221.9M. Net income was -$543.3M. Revenue was up 2285.3% from 2023-12-31 to 2024-12-31. BBIO currently screens at market cap $13.24B.
ASML currently screens at market cap $665.37B and trailing P/E 57.5. BBIO currently screens at market cap $13.24B.
Not investment advice. Open the ASML and BBIO stock pages for the full models.
Not investment advice.